Amended and Restated Collaboration and License Agreement between ADC Therapeutics Sarl and Genmab A/SCollaboration and License Agreement • March 18th, 2021 • ADC Therapeutics SA • Pharmaceutical preparations • New York
This Amended and Restated Collaboration and License Agreement (“Agreement”) is made and entered into on 29 October, 2020 (“Execution Date”), but effective as of 14 June, 2013 (“Effective Date”), by and between ADC Therapeutics Sarl, a Swiss corporation, having its head office at Rue Saint-Pierre 2, Lausanne, 1003, Switzerland (“ADCT”), and Genmab A/S, a Danish corporation, having its principal place of business at Kalvebod Brygge 43, 1560 Copenhagen V, Denmark, CVR no. 2102 3884 (“Genmab”) and amends that certain Collaboration and License Agreement between the Parties dated 14 June 2013 as further amended on 20 November, 2013 and June 24, 2020 (collectively, the “Collaboration Agreement”). Genmab and ADCT are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
DATE: 28 January 2021 Leaserelating to LEVEL 7THE TRANSLATION AND INNOVATION HUB,IMPERIAL COLLEGE WHITE CITY CAMPUS,LONDON W12 Part of estate building (office)(RPI Indexed Rent) BetweenIMPERIAL COLLEGE THINKSPACE LIMITED ADC THERAPEUTICS (UK) LTD...Lease Agreement • March 18th, 2021 • ADC Therapeutics SA • Pharmaceutical preparations • England and Wales
This part of the Lease summarises some of the key terms of this Lease but does not form part of the Lease. In the event of any conflict the remainder of this Lease shall take precedence.
SHARE PURCHASE AGREEMENTShare Purchase Agreement • March 18th, 2021 • ADC Therapeutics SA • Pharmaceutical preparations • New York
FIRST AMENDMENT TO REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 18th, 2021 • ADC Therapeutics SA • Pharmaceutical preparations • New York
This FIRST AMENDMENT TO REGISTRATION RIGHTS AGREEMENT (this “Amendment”) is made as of December 11, 2020 and amends that certain Registration Rights Agreement, dated as of May 19, 2020 (the “Original Agreement”), by and among ADC Therapeutics SA, a Swiss stock corporation (société anonyme) (the “Company”), and Deerfield Partners, L.P. and Deerfield Private Design Fund IV, L.P (each individually, a “Lender” and together, the “Lenders”). All capitalized terms used and not otherwise defined herein shall have the meanings ascribed to them in the Original Agreement.
LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • March 18th, 2021 • ADC Therapeutics SA • Pharmaceutical preparations • New York
ADC Therapeutics SA, a corporation organized and existing under the laws of Switzerland and having a business address at Biopôle, Route de la Corniche 3B, 1066 Epalinges, Switzerland (“ADCT”), and
SHAREHOLDERS AGREEMENTShareholders Agreement • March 18th, 2021 • ADC Therapeutics SA • Pharmaceutical preparations • New York
